<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS94921</article-id>
<article-id pub-id-type="doi">10.1101/2020.09.09.289850</article-id>
<article-id pub-id-type="archive">PPR212341</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptomic dysregulations associated with SARS-CoV-2 infection in human nasopharyngeal and peripheral blood mononuclear cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Boas de Melo</surname>
<given-names>Caroline Vilas</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<email>caroline.melo@aluno.bahia.fiocruz.br</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhuiyan</surname>
<given-names>Maruf Ahmed</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<email>dr.marufahmed89@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gatua</surname>
<given-names>Winfred Nyoroka</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<email>winfredgatua13@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kanyerezi</surname>
<given-names>Stephen</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<email>kanyerezi30@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Uzairue</surname>
<given-names>Leonard</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
<email>uzairue.leonard@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abechi</surname>
<given-names>Priscilla</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
<email>barlicep@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kumar</surname>
<given-names>Karan</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
<email>karaniitg.pmrf18@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rahmat</surname>
<given-names>Jabale</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
<email>rahmat.jabale03oct@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giwa</surname>
<given-names>Abdulazeez</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
<email>giwa.ao@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mwandira</surname>
<given-names>Gracious</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
<email>grapemw@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Olamilekan</surname>
<given-names>Abisogun Mujib</given-names>
</name>
<xref ref-type="aff" rid="A11">11</xref>
<email>olamilekanmujib@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>George</surname>
<given-names>Tiffany Ezinne</given-names>
</name>
<xref ref-type="aff" rid="A12">12</xref>
<email>zurielgee08@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adejinmi</surname>
<given-names>Oluwapelumi John</given-names>
</name>
<xref ref-type="aff" rid="A13">13</xref>
<email>oluwapelumijohnadejinmi@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ibironke</surname>
<given-names>Monsurat Ademidun</given-names>
</name>
<xref ref-type="aff" rid="A14">14</xref>
<email>monsuratibironke994@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rotimi</surname>
<given-names>Olayemi David</given-names>
</name>
<xref ref-type="aff" rid="A15">15</xref>
<email>olayemirotimi3@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abo-Elenein</surname>
<given-names>Dina Aly Mahmoud Aly</given-names>
</name>
<xref ref-type="aff" rid="A16">16</xref>
<email>dinaalymahmoud332@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abubakar</surname>
<given-names>Ridwanullah Abiodun</given-names>
</name>
<xref ref-type="aff" rid="A17">17</xref>
<email>abubakarridwanullah@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Usman</surname>
<given-names>Mahmood</given-names>
</name>
<xref ref-type="aff" rid="A18">18</xref>
<email>mahmoodusman13@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adewunmi</surname>
<given-names>Ifeoluwa</given-names>
</name>
<xref ref-type="aff" rid="A19">19</xref>
<email>iadewunmi39@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akinpelu</surname>
<given-names>Oyewumi</given-names>
</name>
<xref ref-type="aff" rid="A20">20</xref>
<email>akinpeluoyewumibusola@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Emmanuel</surname>
<given-names>Olajide</given-names>
</name>
<xref ref-type="aff" rid="A21">21</xref>
<email>pheemmmy@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reang</surname>
<given-names>Khatendra</given-names>
</name>
<xref ref-type="aff" rid="A22">22</xref>
<email>rkyokmusic@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Olalekan</surname>
<given-names>Akadiri</given-names>
</name>
<xref ref-type="aff" rid="A23">23</xref>
<email>akadirilekan9@gmail.com</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carl</surname>
<given-names>Sarah H.</given-names>
</name>
<xref ref-type="aff" rid="A24">24</xref>
<email>sarahhcarl@gmail.com</email>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Laboratório de Patologia Estrutural e Molecular, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Rua Waldemar Falcão, 121, Candeal - Salvador, Brazil. CEP: 40296-710</aff>
<aff id="A2">
<label>2</label>Department of Virology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, 1000, Bangladesh</aff>
<aff id="A3">
<label>3</label>A. Department of Biochemistry and Biotechnology, Pwani University, P.O.BOX 195-80108 KILIFI, Kenya; B. Molecular Biology and Bioinformatics Unit, International Centre of Insect Physiology and Ecology, P.O.BOX 30772-00100 NAIROBI, Kenya</aff>
<aff id="A4">
<label>4</label>Department of Immunology and Molecular biology, College of Health Sciences, Makerere University. Kampala, Uganda, 7072</aff>
<aff id="A5">
<label>5</label>Department of Microbiology, College of Bioscience, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria, 3100001</aff>
<aff id="A6">
<label>6</label>NGN, Biological sciences, African Center For Excellence In Genomics Of Infectious Diseases (ACEGID), Redeemer's University Ede Osun state</aff>
<aff id="A7">
<label>7</label>Centre for Energy, Indian Institute of Technology Guwahati, Guwahati, Assam- 781039, India</aff>
<aff id="A8">
<label>8</label>School of Life Sciences Independent University, Bangladesh (IUB) Plot 16 Aftab Uddin Ahmed Rd, Dhaka 1229</aff>
<aff id="A9">
<label>9</label>South African National Bioinformatics Institute, University of the Western Cape, South Africa</aff>
<aff id="A10">
<label>10</label>University of Malawi, College of Medicine, Biomedical Sciences department, Private bag 360, Chichiri Blantyre 3</aff>
<aff id="A11">
<label>11</label>Department of Cell Biology and Genetics (Genetics), University of Lagos, Lagos Nigeria</aff>
<aff id="A12">
<label>12</label>Biotechnology, Federal University of Technology, Owerri (FUTO), Owerri Imo State Nigeria, 4130231</aff>
<aff id="A13">
<label>13</label>College of Medicine, University of Ibadan</aff>
<aff id="A14">
<label>14</label>Department of Botany, Lagos State University, KM 15, Badagry Expressway, Ojo, PMB 0001, LASU Post Office, Ojo, Lagos, Nigeria</aff>
<aff id="A15">
<label>15</label>Biochemistry, Ekiti State University, Ekiti State University, PMB 5363, Iworoko road, Ado Ekiti, Ekiti State. Nigeria. Pincode: 362001</aff>
<aff id="A16">
<label>16</label>Zoology Department, Cairo Science University</aff>
<aff id="A17">
<label>17</label>Department of Physiology, University of Ilorin, Nigeria PMB 1515</aff>
<aff id="A18">
<label>18</label>Anatomy Department, Ahmadu Bello University, Zaria – Nigeria</aff>
<aff id="A19">
<label>19</label>Physiology, University of Ibadan, Nigeria</aff>
<aff id="A20">
<label>20</label>University of Strathclyde, Glasgow, United Kingdom, G1 1XQ</aff>
<aff id="A21">
<label>21</label>Nematology Research Unit, Department of Biology, Ghent University, K.L. Ledeganckstraat 35, 9000 Gent, Belgium</aff>
<aff id="A22">
<label>22</label>Hislop College, Biochemistry Department, Chitnavis Centre, Temple Rd, Dobhi Nagar, Civil Lines, Nagpur, Maharashtra 440001</aff>
<aff id="A23">
<label>23</label>Biotechnology, Federal Institute of Industrial Research Oshodi Lagos, Nigeria</aff>
<aff id="A24">
<label>24</label>Scailyte AG, Industriestrasse 12, 6210 Sursee, Switzerland</aff>
<author-notes>
<corresp id="CR1">
<bold>Corresponding authors:</bold> Caroline Vilas Boas de Melo, Ph.D. Laboratório de Patologia Estrutural e Molecular, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Rua Waldemar Falcão, 121, Candeal - Salvador, Brazil. CEP: 40296-710 <email>caroline.melo@aluno.bahia.fiocruz.br</email>; Stephen Kanyerezi, MSc. Department of Immunology and Molecular biology, College of Health Sciences, Makerere University. Kampala, Uganda, 7072. <email>kanyerezi30@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>11</day>
<month>09</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>09</day>
<month>09</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<sec id="S1">
<title>Introduction</title>
<p id="P1">Over 24 million people have been infected globally with the novel coronavirus, SARS-CoV-2, with more than 820,000 succumbing to the resulting COVID-19 disease as of the end of August 2020. The molecular mechanisms underlying the pathogenesis of the disease are not completely elucidated. Thus, we aim to understand host response to SARS-CoV-2 infection by comparing samples collected from two distinct compartments (infection site and blood), obtained from COVID-19 subjects and healthy controls.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">We used two publicly available gene expression datasets generated via RNA sequencing in two different samples; nasopharyngeal swabs and peripheral blood mononuclear cells (PBMCs). We performed a differential gene expression analysis between COVID-19 subjects and healthy controls in the two datasets and then functionally profiled their differentially expressed genes (DEGs). The genes involved in innate immunity were also determined.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">We found a clear difference in the host response to SARS-CoV-2 infection between the two sample groups. In COVID-19 subjects, the nasopharyngeal sample group indicated upregulation of genes involved in cytokine activity and interferon signalling pathway, as well as downregulation of genes involved in oxidative phosphorylation and viral transcription. Host response in COVID-19 subjects for the PBMC group, involved upregulation of genes involved in the complement system and immunoglobulin mediated immune response. <italic>CXCL13</italic>, <italic>GABRE</italic>, <italic>IFITM3</italic> were upregulated and <italic>HSPA1B</italic> was downregulated in COVID-19 subjects in both sample groups.</p>
</sec>
<sec id="S4">
<title>Conclusion</title>
<p id="P4">Our results indicate the host response to SARS-CoV-2 is compartmentalized and suggests potential biomarkers of response to SARS-CoV-2 infection.</p>
</sec>
</abstract>
<kwd-group>
<kwd>SARS-CoV-2</kwd>
<kwd>COVID-19</kwd>
<kwd>Transcriptomic analysis</kwd>
<kwd>Nasopharyngeal swab</kwd>
<kwd>PBMC</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S5" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p id="P5">The ongoing global pandemic in 2020, is a viral outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with over 24 million confirmed cases that account for more than 820,000 confirmed deaths across the world (<xref ref-type="bibr" rid="R28">Pharmaceutical Technology, 2020</xref>). SARS-CoV-2 belongs to the coronavirus family (Coronaviridae) of viruses that cause mild or fatal respiratory tract infections in humans. The virus is contagious and infects humans by entering the cells through the attachment of its spike proteins to angiotensin-converting enzyme 2 (ACE2) receptors found on surface of the cell (<xref ref-type="bibr" rid="R24">Mathewson et al., 2008</xref>; <xref ref-type="bibr" rid="R33">Shereen et al., 2020</xref>; <xref ref-type="bibr" rid="R37">Wang et al., 2020</xref>). The clinical manifestations of the disease caused by SARS-CoV-2, coronavirus disease 2019 (COVID-19) include fever, dry cough, breathing difficulties (dyspnoea), headache and fatigue (<xref ref-type="bibr" rid="R21">Lima, 2020</xref>; <xref ref-type="bibr" rid="R5">CDC, 2019</xref>). Other symptoms observed in some patients are sore throat in the prominent upper respiratory tract, sneezing, anosmia and rhinorrhoea (<xref ref-type="bibr" rid="R15">Huang et al., 2020</xref>, <xref ref-type="bibr" rid="R14">Hornuss et al., 2020</xref>; <xref ref-type="bibr" rid="R18">Lee et al., 2020</xref>; <xref ref-type="bibr" rid="R17">Lechien et al., 2020</xref>).</p>
<p id="P6">Although there is an expression of interferon (IFN) in other coronavirus infections (<xref ref-type="bibr" rid="R26">Newton <italic>et al</italic>., 2016</xref>; <xref ref-type="bibr" rid="R25">Nelemans &amp; Kikkert, 2019</xref>), some studies on the immune response to viral infections in addition to the newly understanding of SARS-CoV-2, established that the virus suppresses various mechanisms in the interferon pathway thereby preventing the pattern recognition receptors (PRR), signalling and inhibiting host protein translation (<xref ref-type="bibr" rid="R26">Newton <italic>et al</italic>., 2016</xref>; <xref ref-type="bibr" rid="R25">Nelemans &amp; Kikkert, 2019</xref>; <xref ref-type="bibr" rid="R19">Lei <italic>et al</italic>., 2020</xref>; <xref ref-type="bibr" rid="R23">Mantlo <italic>et al</italic>., 2020</xref>). Previous studies also established that triggering of such exuberant inflammatory responses in the host leads to severe lung disease (<xref ref-type="bibr" rid="R7">Channappanavar <italic>et al</italic>., 2016</xref>). Most COVID-19 patients with severe clinical presentation and poor prognosis exhibit dysregulated host immune response and enhanced levels of pro-inflammatory cytokines known as the “cytokine storm” (<xref ref-type="bibr" rid="R15">Huang <italic>et al</italic>., 2020</xref>). Recent studies done by <xref ref-type="bibr" rid="R15">Haung <italic>et al.</italic> (2020)</xref> and <xref ref-type="bibr" rid="R38">Xiong <italic>et al.</italic> (2020)</xref> also demonstrated elevated amounts of plasma <italic>IL2</italic>, <italic>IL6</italic>, <italic>IL7</italic>, <italic>IL10</italic>, <italic>GCSF</italic>, <italic>IP10</italic>, <italic>MCP1</italic>, <italic>MIP1A</italic>, and <italic>TNFα</italic> in severe cases of COVID-19 compared to mild cases, showing inflammatory cytokines release to be significantly associated with COVID-19 progression (<xref ref-type="bibr" rid="R15">Huang <italic>et al</italic>., 2020</xref>, <xref ref-type="bibr" rid="R38">Xiong <italic>et al</italic>., 2020</xref>).</p>
<p id="P7">Transcriptome profiling allows the evaluation of gene expression changes in response to disease or treatment (<xref ref-type="bibr" rid="R36">Voineagu <italic>et al</italic>. 2011</xref>). Transcriptome profiling of 8356 cells collected from COVID-19 patients and healthy controls revealed that COVID-19 patients exhibited abnormalities in their bronchoalveolar epithelial cells and that the SARS-CoV-2 virus suppresses gene expression in host cells (<xref ref-type="bibr" rid="R13">He <italic>et al</italic>., 2020</xref>). However, the underlying molecular mechanisms of the inflammatory responses and pathogenesis of the COVID-19 in SARS-CoV-2 infection are not clearly understood. Thus, analysing host transcriptional changes in response to SARS-CoV-2 infection is necessary to help describe the biological process underlying the pathogenesis of COVID-19.</p>
<p id="P8">In this study, we performed transcriptomic analysis of different samples sources from both COVID-19 patients and healthy controls (<xref ref-type="fig" rid="F1">Figure 1</xref>). We show that transcriptional response to SARS-CoV-2 infection in the two different compartments are distinct and reflect a local inflammation in nasopharyngeal site and circulating immune response in peripheral blood mononuclear cells (PBMC) samples in COVID-19 patients.</p>
</sec>
<sec id="S6" sec-type="materials | methods">
<label>2</label>
<title>Material and Methods</title>
<sec id="S7">
<label>2.1</label>
<title>Study design and datasets</title>
<p id="P9">This is a secondary study from publicly available data. Gene expression data (RNA-Seq counts) of GSE152418 and GSE152075 datasets were downloaded from the NCBI Gene Expression Omnibus (GEO) database. The GSE152075 dataset was generated by RNA sequencing of nasopharyngeal swab samples from COVID-19 subjects and healthy controls (<xref ref-type="bibr" rid="R29">Randhawa et al., 2020</xref>; <xref ref-type="bibr" rid="R20">Lieberman <italic>et al</italic>., 2020</xref>). The dataset was composed of 430 nasopharyngeal swab samples of COVID-19 subjects and 54 of healthy controls. The median age (years) of the COVID-19 patients enrolled in the study was 54 [2 - 98] in which the majority was female (43%; unknown: 12%) (<xref ref-type="bibr" rid="R20">Lieberman <italic>et al</italic>., 2020</xref>). The GSE152418 dataset was generated by RNA sequencing of PBMCs from COVID-19 subjects and healthy controls (<xref ref-type="bibr" rid="R1">Arunachalam et al., 2020</xref>). The dataset was composed of 16 PBMC samples of COVID-19 subjects and of 17 healthy controls. The median age (years) of the COVID-19 patients was 56 [25 - 94] with a majority of male (55%) (<xref ref-type="bibr" rid="R1">Arunachalam et al., 2020</xref>). SARS-CoV-2 infection was confirmed by RT-PCR in both studies. Nasopharyngeal samples were collected in the emergency departments on admission of the patients and PBMC samples during hospitalization.</p>
</sec>
<sec id="S8">
<label>2.2</label>
<title>Differentially expressed gene (DEGs) analysis</title>
<p id="P10">DEGs analysis was performed on the control and disease samples in each nasopharyngeal and PBMC group using the DESeq2 package in R (<xref ref-type="bibr" rid="R22">Love et al., 2014</xref>). Genes that fulfilled the criteria of an adjusted <italic>p</italic>-value &lt; 0.05 and a threshold of log2 fold change &gt; 1 were considered significant. Ensembl IDs were converted to HUGO Gene Nomenclature Committee (HGNC) symbols using the g: Convert tool in g: Profiler (<xref ref-type="bibr" rid="R30">Raudvere et al., 2019</xref>). The common DEGs in both the nasopharyngeal and PBMC samples were identified. An ensemble of hierarchical and k-means clustering was then applied to these common DEGs to determine their discriminatory utility of the samples into their respective sample groups (i.e. Nasopharyngeal or PBMC). The DEGs were also searched for their involvement in innate immunity using the InnateDB database (<xref ref-type="bibr" rid="R3">Breuer et al., 2013</xref>).</p>
</sec>
<sec id="S9">
<label>2.3</label>
<title>Gene enrichment analysis</title>
<p id="P11">Functional profiling of the upregulated and downregulated DEGs in the two sample groups were carried out using the g:GOSt tool in g: Profiler (<xref ref-type="bibr" rid="R30">Raudvere <italic>et al</italic>., 2019</xref>) with adjusted p-value &lt; 0.05 set as cut off for significant terms.</p>
</sec>
<sec id="S10">
<label>2.4</label>
<title>Expression of the results</title>
<p id="P12">The results were expressed in tables, graphs and illustrations when convenient. Heatmaps of the top 20 genes (10 up regulated and 10 down regulated) in both datasets were plotted using iDEP.91 server. The hkmeans and dendrogram plot functions were applied to a normalised data matrix of both nasopharyngeal and PBMC samples using software Orange Data Mining (Ljubljana University). Functional analysis was plotted using Prism (GraphPad software, Inc).</p>
</sec>
</sec>
<sec id="S11" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="S12">
<label>3.1</label>
<title>Transcriptome profiling of host response to SARS-CoV-2 infection from nasopharyngeal and PBMC samples</title>
<p id="P13">An overview of the gene expression in nasopharyngeal and PBMCs sample groups was observed in the principal component analysis (PCA), which suggests how significant the variation among the gene expression was between the two groups (<xref ref-type="fig" rid="F2">Figure 2</xref>). In nasopharyngeal samples, we observed a separation between healthy controls and COVID-19 subjects along the second principal component, although substantial overlap between groups remained (<xref ref-type="fig" rid="F2">Figure 2, A</xref>). A distinct cluster between healthy controls and cases was observed in the PBMC sample group (<xref ref-type="fig" rid="F2">Figure 2, B</xref>). Next, we performed a differential gene expression analysis relative to matched healthy controls, to explore host response to SARS-CoV-2 infection (<xref ref-type="fig" rid="F2">Figure 2</xref>). In the nasopharyngeal sample group, 745 genes were differentially expressed, of which 166 were upregulated, and 579 were downregulated (<xref ref-type="fig" rid="F2">Figure 2, C</xref>). In the PBMC sample group, 532 genes were differentially expressed, of which 524 were upregulated and 8 were downregulated (<xref ref-type="fig" rid="F2">Figure 2, D</xref>).</p>
</sec>
<sec id="S13">
<label>3.2</label>
<title>SARS-CoV-2 infection induces a differential expression pattern in nasopharyngeal and PBMC sample groups</title>
<p id="P14">From the number of differentially expressed genes, we next sought to contrast and explore the quantitative changes between the sample groups relative to respective healthy controls. The top significant DEGs evidence a distinct expression pattern in the two sample groups (<xref ref-type="fig" rid="F3">Figure 3</xref>, <xref ref-type="supplementary-material" rid="SD5">Tables S1</xref> and <xref ref-type="supplementary-material" rid="SD1">S2</xref>). Thirteen DEGs including <italic>CLU</italic>, <italic>CXCL13</italic>, <italic>GABRE</italic>, <italic>HSPA1B</italic>, <italic>IFITM3</italic>, <italic>IGHA2</italic>, <italic>IGHG1</italic>, <italic>IGHG3</italic>, <italic>ITGB5</italic>, <italic>MT1E</italic>, <italic>SELENBP1</italic>, <italic>TXNDC5</italic> and <italic>UCHL1</italic> were found to be commonly expressed between both sample groups. These genes encode for immunoglobulins, chemokines, ubiquitin, and proteins responsible for stress response and protein degradation. The genes <italic>CXCL13</italic>, <italic>GABRE</italic> and <italic>IFITM3,</italic> were upregulated in COVID-19 subjects in both sample groups. The genes <italic>CLU</italic>, <italic>IGHA2</italic>, <italic>IGHG1</italic>, <italic>IGHG3</italic>, <italic>ITGB5</italic>, <italic>MT1E</italic>, <italic>SELENBP1</italic>, <italic>TXNDC5</italic> and <italic>UCHL1</italic> were upregulated in COVID-19 subjects in the PBMC group but downregulated in COVID-19 subjects in the nasopharyngeal sample group. <italic>HSPA1B</italic> was downregulated in both sample groups. The expression pattern of these 13 commonly DEGs consistently discriminated nasopharyngeal and PBMC samples amongst the COVID-19 subjects by hierarchical clustering (<xref ref-type="fig" rid="F3">Figure 3, C</xref>).</p>
</sec>
<sec id="S14">
<label>3.3</label>
<title>Host immune and metabolic response to SARS-CoV-2 infection</title>
<p id="P15">To evaluate biological relevance, we enriched the interaction between the DEGs. Functional profiling of the nasopharyngeal upregulated DEGs identified significant terms such as chemokine activity, cytokine activity, inflammatory response, and type 1 interferon signalling pathway (<xref ref-type="fig" rid="F4">Figure 4, A</xref>), indicating a cellular-mediated immune response. Functional profiling of the upregulated DEGs in COVID-19 subjects in the PBMC group identified significant terms such as immunoglobulin receptor binding, B cell-mediated immunity, complement activation, haemoglobin binding, oxygen carrier activity and cell division (<xref ref-type="fig" rid="F4">Figure 4, B</xref>). The transcriptional profile shown by PBMCs reflects a humoral and complement mediated response against SARSCoV-2 infection. Ninety-two (92) of the DEGs in the nasopharyngeal group were found to be involved in innate immunity, of which 53 were upregulated, and 39 were downregulated. Functional profiling of the downregulated DEGs in the nasopharyngeal sample identified significant terms such as RNA binding, oxidoreductase activity, cytochrome-c-oxidase activity, oxidative phosphorylation, viral transcription and selenocysteine synthesis (<xref ref-type="supplementary-material" rid="SD3">Table S5</xref>). There were only 8 downregulated genes in the PBMCs sample group and they were not functionally enriched. Forty-three (43) of the DEGs in the COVID-19 subjects in the PBMC sample group were found to be involved in innate immunity and were all upregulated. Result tables of functional profiling of DEGs are available in the <xref ref-type="supplementary-material" rid="SD4">Supplementary Tables S3</xref> to <xref ref-type="supplementary-material" rid="SD3">S5</xref>. In summary, functional profiling of the DEGs involved in innate immunity in both sample groups identified terms indicating host response to the viral challenge, but distinct pathways of the immune response. For nasopharyngeal sample groups, the events suggest a cellular-mediated immune response, whereas a humoral-mediated response was observed in the PBMC sample group (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
</sec>
</sec>
<sec id="S15" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p id="P16">This study was designed to analyse host transcriptional changes in response to COVID-19 from publicly available datasets, to contribute to the knowledge of the biological processes underlying the pathogenesis of COVID-19 and the immune responses elicited. Our results showed a distinct immune response in nasopharyngeal samples and PBMC samples in COVID-19 patients, as evidenced by the differential expression pattern. We have shown that apart from a compartmentalized and site-specific immune response, there was a set of genes commonly regulated in the two sample groups. These observations are in line with previous reports in which SARS-CoV-2 infection induces a highly inflammatory environment observed in nasopharyngeal samples and an innate immune response played by complement system in PBMCs (<xref ref-type="bibr" rid="R2">Blanco-Melo et al., 2020</xref>; <xref ref-type="bibr" rid="R38">Xiong et al., 2020</xref>).</p>
<p id="P17">We showed that nasopharyngeal samples exhibited a regulation for local inflammation, compatible with the tropism of SARS-CoV-2 to nasal epithelial cells (<xref ref-type="bibr" rid="R35">Sungnak et al., 2020</xref>). This response was shown to be specific at the infection site, that likely reflect in complementary and systemic elements of immune response in the periphery, as indicated in this study. The infection by SARS-CoV-2 is marked by a systemic inflammatory response that affects various organs in different manners (<xref ref-type="bibr" rid="R10">Gardinassi et al., 2020</xref>). Although the elevated inflammatory response may be beneficial in fighting the infection, it may also lead to an over-production of pro-inflammatory cytokines that may cause damage to the olfactory epithelium, as well as adverse outcomes such as alveolar damage, respiratory failure and multiple organ dysfunction (<xref ref-type="bibr" rid="R6">Chen et al., 2017</xref>.; <xref ref-type="bibr" rid="R15">Huang et al., 2020</xref>; <xref ref-type="bibr" rid="R38">Xiong et al., 2020</xref>). Cytokines have been shown to contribute to leukocyte recruitment via activating integrins, promoting migration of adherent leukocytes across endothelium and through the extracellular matrix (<xref ref-type="bibr" rid="R4">Butcher et al., 1996</xref>). Therefore, cytokine and chemokine expression in the nasopharynx is possibly associated with the finding of upregulation of leukocytes migration. <xref ref-type="bibr" rid="R2">Blanco-Melo and colleagues (2020)</xref>, observed a strong chemokine expression in transcriptomic profile from nasopharyngeal swabs and low levels of IFN-I. In contrast to that, through the functional profiling in nasopharyngeal samples, we observed an activity regulated by Type I Interferon. In this study, the soluble levels of IFN-I were not addressed, but a possible counterbalance played by upregulation of anti-inflammatory signalling by IL-10 could be in line to what was observed by <xref ref-type="bibr" rid="R2">Blanco-Melo and colleagues (2020)</xref>. <xref ref-type="bibr" rid="R12">Hachim <italic>et al.</italic> (2020)</xref> also reported that genes, especially the <italic>IFITM3</italic> gene, involved in IFN response to a viral infection such as type 1 interferon signalling pathway, were upregulated in SARS-CoV-2 infected lung epithelial cells. This further elucidates the release of IFN by the innate immune system in response to viral RNAs, such as is the case with SARS-CoV-2 (<xref ref-type="bibr" rid="R25">Nelemans &amp; Kikkert, 2019</xref>). Further investigation on the mechanism of recruitment and effector function of responding cells is required in order to better understand the process. The biological processes found in PBMCs are consistently directed towards a humoral-mediated response. <xref ref-type="bibr" rid="R38">Xiong and colleagues (2020)</xref> reported similar results from PBMCs, with the observation that genes upregulated in PBMCs of COVID-19 patients were enriched in complement activation, B cell-mediated immunity, and immunoglobulin-mediated humoral immune response. These results indicate a highly specific immune response in periphery. Indeed, <xref ref-type="bibr" rid="R34">Stahel and Barnum (2020)</xref> pointed out the importance of the complement system in the pathogenesis of COVID-19. Our results support the need for further studies to uncover the exact mechanism of the complement system in COVID-19.</p>
<p id="P18">A molecular signature is observed in the heatmap from PBMCs, albeit not so clearly in nasopharyngeal samples. The sample size, higher in nasopharyngeal sampling, may reflect heterogeneous observations from possible diverse clinical presentations. The fact we have found a specific cellular-mediated immune response in nasopharyngeal samples, even in a heterogeneous group of patients, reinforces the importance of the finding of commonly dysregulated genes with the PBMC sample group. Heat Shock Protein Family A (Hsp70) Member 1B - <italic>HSPA1B</italic> was downregulated in both sample groups. <italic>HSPA1B</italic> codes for a molecular chaperone that plays a vital role in cellular processes including protection of protein from stress and protein quality control system including correct folding of proteins (<xref ref-type="bibr" rid="R16">Kim &amp; Oglesbee, 2012</xref>; <xref ref-type="bibr" rid="R32">Scieglinska <italic>et al.</italic>, 2019</xref>). In addition, it has been found that viral infection stimulates <italic>HSPA1B</italic> the gene to increase its own replication (<xref ref-type="bibr" rid="R16">Kim &amp; Oglesbee, 2012</xref>). Therefore, during the viral infection of SARS-CoV-2, downregulation of <italic>HSP1AB</italic> might be an indirect immune response from the host to decrease the viral load by reducing the rate of translation of viral protein molecules. We highlight the need of further research to assess the effect of other RNA viruses on the expression of <italic>HSP1AB</italic> genes and whether the suppression of the gene benefits the host against the viral infection. Chemokine (C-XC motif) ligand 13 - <italic>CXCL13</italic> preferentially promotes migration of B lymphocytes into follicles. Interferon Induced Transmembrane Protein 3 - <italic>IFITM3</italic> is a protein-coding gene that disrupts the intracellular cholesterol homeostasis and inhibits the entry of viruses to the cell cytoplasm by hindering fusion of the virus with cholesterol depleted endosomes. <italic>IFITM3</italic> is an interferon induced gene that aids in providing immunity against the viral infections (<xref ref-type="bibr" rid="R8">Feeley et al., 2011</xref>). Together with downregulated <italic>HSP1AB</italic> and the upregulated genes <italic>CXCL13</italic> and <italic>IFITM3</italic>, we draw attention to these molecules as potential biomarkers of disease progression. <italic>CXCL13</italic> plays a vital role in the migration of B cells during viral infection (<xref ref-type="bibr" rid="R27">Phares <italic>et al.,</italic> 2016</xref>) and <italic>IFITM3</italic> is also involved in antiviral response (<xref ref-type="bibr" rid="R39">Zhang <italic>et al.,</italic> 2020</xref>). This may be due to association with the activation of the cytokine storm in infected patients during immune response (<xref ref-type="bibr" rid="R9">Gao <italic>et al.,</italic> 2020</xref>; <xref ref-type="bibr" rid="R15">Huang <italic>et al.,</italic> 2020</xref>; <xref ref-type="bibr" rid="R31">Ruan <italic>et al</italic>., 2020</xref>). Nevertheless, <xref ref-type="bibr" rid="R12">Hachim <italic>et al.</italic> (2020)</xref> also reported an early upregulation of <italic>IFITM3</italic> in SARS-CoV-2 infected patients. Taken together, the roles in the infection played by these commonly expressed genes at a critical site - possibly the entry route of viral-host interaction in the nasopharynx raises the possibility of low invasive tests to investigate these genes in peripheral blood and support personalized medicine.</p>
<p id="P19">Here, we provided insights on the potential use of transcriptomic data to address site-specific differential gene expression in response to SARS-CoV-2. Our results direct the potential of markers to discriminate sample source and differential host response to SARS-CoV-2 and possibly other viral infections. Altogether, we suggest further investigation of whether the gene products can be used as potential biomarkers as a COVID-19 screening process.</p>
</sec>
<sec id="S16" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p id="P20">Using transcriptomic analysis, we identified differentially expressed genes between COVID-19 subjects in nasopharyngeal and PBMC sample groups in comparison to healthy controls. We also illustrated the prominent immune response genes involved in SARS-CoV-2 infection in both sample types. The differential expression profile observed between the sample groups suggests the existence of different markers of the infection and which may possibly have diagnostic and/or prognostic utility in COVID-19. However, further studies are required to fully characterise the genes involved in the SARS-CoV-2 infection.</p>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Table S2</label>
<media xlink:href="EMS94921-supplement-Table_S2.docx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" id="N66827" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>Table S4</label>
<media xlink:href="EMS94921-supplement-Table_S4.docx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" id="N66836" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD3">
<label>Table S5</label>
<media xlink:href="EMS94921-supplement-Table_S5.docx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" id="N66845" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD4">
<label>Table S3</label>
<media xlink:href="EMS94921-supplement-Table_S3.docx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" id="N66854" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD5">
<label>Table S1</label>
<media xlink:href="EMS94921-supplement-Table_S1.docx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" id="N66863" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD6">
<label>Supplemental Information</label>
<media xlink:href="EMS94921-supplement-Supplemental_Information.pdf" mimetype="application" mime-subtype="pdf" id="N66872" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>COVID-19</term>
<def>
<p>Corona viral disease-2019</p>
</def>
</def-item>
<def-item>
<term>SARS-CoV-2</term>
<def>
<p>Severe acute respiratory syndrome coronavirus-2</p>
</def>
</def-item>
<def-item>
<term>PBMC</term>
<def>
<p>Peripheral blood mononuclear cells</p>
</def>
</def-item>
<def-item>
<term>PCA</term>
<def>
<p>Principal component analysis</p>
</def>
</def-item>
<def-item>
<term>GSE</term>
<def>
<p>Gene set enrichment</p>
</def>
</def-item>
<def-item>
<term>CXCL13</term>
<def>
<p>Chemokine ligand 13</p>
</def>
</def-item>
<def-item>
<term>GABRE</term>
<def>
<p>Gamma-aminobutyric acid receptor subunit epsilon</p>
</def>
</def-item>
<def-item>
<term>IFITM3</term>
<def>
<p>Interferon (IFN)-induced transmembrane proteins</p>
</def>
</def-item>
<def-item>
<term>HSPA1B</term>
<def>
<p>Heat shock protein family A (Hsp70) member 1B</p>
</def>
</def-item>
<def-item>
<term>IL2</term>
<def>
<p>Interleukin-2</p>
</def>
</def-item>
<def-item>
<term>IL6</term>
<def>
<p>Interleukin-6</p>
</def>
</def-item>
<def-item>
<term>IL7</term>
<def>
<p>Interleukin-7</p>
</def>
</def-item>
<def-item>
<term>IL10</term>
<def>
<p>Interleukin-10</p>
</def>
</def-item>
<def-item>
<term>GCSF</term>
<def>
<p>Granulocyte colony-stimulating factor</p>
</def>
</def-item>
<def-item>
<term>IP10</term>
<def>
<p>Interferon gamma-induced protein 10</p>
</def>
</def-item>
<def-item>
<term>MCP1</term>
<def>
<p>Monocyte chemoattractant protein-1</p>
</def>
</def-item>
<def-item>
<term>MIP1A</term>
<def>
<p>Macrophage inflammatory protein 1-alpha</p>
</def>
</def-item>
<def-item>
<term>TNFα</term>
<def>
<p>tumor necrosis factor alpha</p>
</def>
</def-item>
<def-item>
<term>IFN</term>
<def>
<p>Interferon</p>
</def>
</def-item>
<def-item>
<term>CLU</term>
<def>
<p>Clusterin</p>
</def>
</def-item>
<def-item>
<term>IGHA2</term>
<def>
<p>Immunoglobulin heavy constant alpha 2</p>
</def>
</def-item>
<def-item>
<term>IGHG1</term>
<def>
<p>Immunoglobulin heavy constant gamma 1</p>
</def>
</def-item>
<def-item>
<term>IGHG3</term>
<def>
<p>Immunoglobulin heavy constant gamma 3</p>
</def>
</def-item>
<def-item>
<term>ITGB5</term>
<def>
<p>Integrin β5</p>
</def>
</def-item>
<def-item>
<term>MT1E</term>
<def>
<p>Metallothionein 1E</p>
</def>
</def-item>
<def-item>
<term>SELENBP1</term>
<def>
<p>Selenium binding protein 1</p>
</def>
</def-item>
<def-item>
<term>TXNDC5</term>
<def>
<p>Thioredoxin domain containing 5</p>
</def>
</def-item>
<def-item>
<term>UCHL1</term>
<def>
<p>Ubiquitin C-terminal hydrolase L1</p>
</def>
</def-item>
</def-list>
</glossary>
<ack id="S17">
<title>Acknowledgements</title>
<p>We acknowledge HackBio internship, represented by Mr. Adewale Ogunleye, (convenor), Mr. Samson (Head of communication), Mr. Jekayinoluwa (program manager), and Mr. Emmanuel (Head of finance and budget), sponsors and partners of HackBio DNAcompass, CMESBAHF Nigeria, New Life Research Foundation, Galaxy Project, and Biotrust-Scientific. We thank Dr. Washington LC dos-Santos (MD, PhD) for his consultancy in this study. Sarah H Carl, Ph.D., was a mentor for this project.</p>
</ack>
<fn-group>
<fn id="FN1" fn-type="con">
<p id="P21">
<bold>Author contributions</bold>
</p>
<p id="P22">The first three authors have contributed equally. <bold>Caroline Vilas Boas de Melo</bold>
<sup>1</sup>: Conceptualization, data curation, formal analysis, investigation, project administration, resources, validation, visualization, writing - original draft, writing - review &amp; editing; <bold>Maruf Ahmed Bhuiyan</bold>
<sup>2</sup>: Conceptualization, data curation, formal analysis, investigation, methodology, software, resources, validation, visualization, writing - original draft, writing - review &amp; editing; <bold>Winfred Nyoroka Gatua</bold>
<sup>3</sup>: Conceptualization, data curation, formal analysis, investigation, methodology, software, visualization, writing - original draft, writing - review &amp; editing; <bold>Stephen Kanyerezi</bold>
<sup>4</sup>: Conceptualization, data curation, methodology, project administration, software, visualization, writing - original draft, writing - review &amp; editing; <bold>Leonard Uzairue</bold>
<sup>5</sup>: Conceptualization, project administration, resources, writing - original draft, writing - review &amp; editing; <bold>Priscilla Abechi</bold>
<sup>6</sup>: Conceptualization, investigation, project administration, resources, validation, writing - original draft, writing - review &amp; editing; <bold>Karan Kumar</bold>
<sup>7</sup>: Conceptualization, formal analysis, methodology, software, visualization, validation, writing - review &amp; editing; <bold>Jabale Rahmat</bold>
<sup>8</sup>: Conceptualization, resources, validation, visualization, writing - original draft, writing - review &amp; editing; <bold>Abdulazeez Giwa</bold>
<sup>9</sup>: Conceptualization, data curation, formal analysis, methodology, software, writing - original draft, writing - review &amp; editing; <bold>Gracious Mwandira</bold>
<sup>10</sup>: Conceptualization, methodology, visualization, writing - original draft, writing - review &amp; editing; <bold>Abisogun Mujib Olamilekan</bold>
<sup>11</sup>: Conceptualization, methodology, visualization, writing - review &amp; editing; <bold>Tiffany Ezinne George</bold>
<sup>12</sup>: Conceptualization, investigation, resources, writing - original draft; <bold>Oluwapelumi John Adejinmi</bold>
<sup>13</sup>: Conceptualization, writing - original draft, writing - review &amp; editing; <bold>Monsurat Ademidun Ibironke</bold>
<sup>14</sup>: Writing - review &amp; editing; <bold>Olayemi David Rotimi</bold>
<sup>15</sup>: Conceptualization, resources, writing - original draft; <bold>Dina Aly Mahmoud Aly Abo-Elenein</bold>
<sup>16</sup>: Resources, writing - original draft; <bold>Ridwanullah Abiodun Abubakar</bold>
<sup>17</sup>: Conceptualization, resources, validation, writing - original draft, writing - review &amp; editing; <bold>Mahmood Usman</bold>
<sup>18</sup>: Resources, writing - original draft, writing - review &amp; editing; <bold>Ifeoluwa Adewunmi</bold>
<sup>19</sup>: Conceptualization, writing - original draft, writing; <bold>Oyewumi Akinpelu</bold>
<sup>20</sup>: Writing - original draft; <bold>Olajide Emmanuel</bold>
<sup>21</sup>: Conceptualization, resources; <bold>Khatendra Reang</bold>
<sup>22</sup>: Investigation, resources, visualization, writing - original draft; <bold>Akadiri Olalekan</bold>
<sup>23</sup>: Conceptualization, resources, writing - original draft, writing - review &amp; editing; <bold>Sarah H. Carl</bold>
<sup>24</sup>: Supervision, writing - review &amp; editing.</p>
</fn>
<fn id="FN2" fn-type="conflict">
<p id="P23">
<bold>Conflicts of interest statement</bold>
</p>
<p id="P24">The authors have declared there are no conflicts of interest involved in this research.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arunachalam</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Wimmers</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mok</surname>
<given-names>CKP</given-names>
</name>
<name>
<surname>Perera</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hagan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wagh</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans</article-title>
<source>Science</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1126/science.abc6261</pub-id>
</element-citation>
</ref>
<ref id="R2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blanco-Melo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nilsson-Payant</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Uhl</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hoagland</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Møller</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>TT</given-names>
</name>
</person-group>
<article-title>Imbalanced host response to SARS-CoV-2 drives development of COVID-19</article-title>
<source>Cell</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.cell.2020.04.026</pub-id>
</element-citation>
</ref>
<ref id="R3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breuer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Foroushani</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Laird</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sribnaia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lynn</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation</article-title>
<source>Nucleic acids research</source>
<year>2013</year>
<volume>41</volume>
<issue>D1</issue>
<fpage>D1228</fpage>
<lpage>D1233</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gks1147</pub-id>
</element-citation>
</ref>
<ref id="R4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butcher</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Picker</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>Lymphocyte homing and homeostasis</article-title>
<source>Science</source>
<year>1996</year>
<volume>272</volume>
<issue>5258</issue>
<fpage>60</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="doi">10.1126/science.272.5258.60</pub-id>
</element-citation>
</ref>
<ref id="R5">
<element-citation publication-type="book">
<collab>CDC</collab>
<source>Novel Coronavirus Wuhan, China: Symptoms</source>
<publisher-name>CDC</publisher-name>
<year>2019</year>
<comment>Available at <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html">https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>Acute inflammation regulates neuroregeneration through the NF-κB pathway in olfactory epithelium</article-title>
<source>Proceedings of the National Academy of Sciences</source>
<year>2017</year>
<volume>114</volume>
<issue>30</issue>
<fpage>8089</fpage>
<lpage>8094</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1620664114</pub-id>
</element-citation>
</ref>
<ref id="R7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Channappanavar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fehr</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Vijay</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mack</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meyerholz</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Perlman</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice</article-title>
<source>Cell Host &amp; Microbe</source>
<year>2016</year>
<volume>19</volume>
<issue>2</issue>
<fpage>181</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2016.01.007</pub-id>
</element-citation>
</ref>
<ref id="R8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feeley</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>John</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Pertel</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Gaiha</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Donis</surname>
<given-names>RO</given-names>
</name>
<name>
<surname>Elledge</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Brass</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>IFITM3 inhibits influenza A virus infection by preventing cytosolic entry</article-title>
<source>PLoS pathogens</source>
<year>2011</year>
<volume>7</volume>
<issue>10</issue>
<fpage>e1002337</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1002337</pub-id>
</element-citation>
</ref>
<ref id="R9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Diagnostic utility of clinical laboratory data determinations for patients with severe COVID-19</article-title>
<source>Journal of Medical Virology</source>
<year>2020</year>
<volume>92</volume>
<issue>7</issue>
<fpage>791</fpage>
<lpage>796</lpage>
<pub-id pub-id-type="doi">10.1002/jmv.25770</pub-id>
</element-citation>
</ref>
<ref id="R10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gardinassi</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Souza</surname>
<given-names>CO</given-names>
</name>
<name>
<surname>Sales-Campos</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fonseca</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>Immune and metabolic signatures of COVID-19 revealed by transcriptomics data reuse</article-title>
<source>Frontiers in Immunology</source>
<year>2020</year>
<volume>11</volume>
<issue>1636</issue>
<pub-id pub-id-type="doi">10.3389/fimmu.2020.01636</pub-id>
</element-citation>
</ref>
<ref id="R11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ge</surname>
<given-names>SX</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data</article-title>
<source>BMC Bioinformatics</source>
<year>2018</year>
<volume>19</volume>
<issue>1</issue>
<fpage>534</fpage>
<pub-id pub-id-type="doi">10.1186/s12859-018-2486-6</pub-id>
</element-citation>
</ref>
<ref id="R12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hachim</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Al Heialy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hachim</surname>
<given-names>IY</given-names>
</name>
<name>
<surname>Halwani</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Senok</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Maghazachi</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Hamid</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells</article-title>
<source>Frontiers in Immunology</source>
<year>2020</year>
<volume>11</volume>
<fpage>1372</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2020.01372</pub-id>
</element-citation>
</ref>
<ref id="R13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients</article-title>
<source>Protein &amp; Cell</source>
<year>2020</year>
<volume>11</volume>
<issue>9</issue>
<fpage>680</fpage>
<lpage>687</lpage>
<pub-id pub-id-type="doi">10.1007/s13238-020-00752-4</pub-id>
</element-citation>
</ref>
<ref id="R14">
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Hornuss</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lange</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schröter</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rieg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kern</surname>
<given-names>WV</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Anosmia in COVID-19 patients</article-title>
<source>Clinical Microbiology and Infection</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.cmi.2020.05.017</pub-id>
</element-citation>
</ref>
<ref id="R15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>
<article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>
<source>The Lancet</source>
<year>2020</year>
<volume>395</volume>
<issue>10223</issue>
<fpage>497</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id>
</element-citation>
</ref>
<ref id="R16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Oglesbee</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Virus-heat shock protein interaction and a novel axis for innate antiviral immunity</article-title>
<source>Cells</source>
<year>2012</year>
<volume>1</volume>
<issue>3</issue>
<fpage>646</fpage>
<lpage>666</lpage>
<pub-id pub-id-type="doi">10.3390/cells1030646</pub-id>
</element-citation>
</ref>
<ref id="R17">
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Lechien</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Chiesa-Estomba</surname>
<given-names>CM</given-names>
<prefix>MD</prefix>
</name>
<name>
<surname>Hans</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Barillari</surname>
<given-names>MR</given-names>
<prefix>MD</prefix>
</name>
<name>
<surname>Jouffe</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Saussez</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19</article-title>
<source>Annals of Internal Medicine</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.7326/M20-2428</pub-id>
</element-citation>
</ref>
<ref id="R18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>Prevalence and duration of acute loss of smell or taste in COVID-19 patients</article-title>
<source>Journal of Korean medical science</source>
<year>2020</year>
<volume>35</volume>
<issue>18</issue>
<pub-id pub-id-type="doi">10.3346/jkms.2020.35.e174</pub-id>
</element-citation>
</ref>
<ref id="R19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Activation and evasion of type I interferon responses by SARS-CoV-2</article-title>
<source>Nature Communications</source>
<year>2020</year>
<volume>11</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1038/s41467-020-17665-9</pub-id>
</element-citation>
</ref>
<ref id="R20">
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Lieberman</surname>
<given-names>NAP</given-names>
</name>
<name>
<surname>Peddu</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shrestha</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Mears</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Cajimat</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Bente</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>PY</given-names>
</name>
<name>
<surname>Bovier</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Roychoudhury</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>In vivo antiviral host response to SARS-CoV-2 by viral load, sex, and age</article-title>
<source>BioRxiv</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.06.22.165225</pub-id>
<comment>2020.06.22.165225</comment>
</element-citation>
</ref>
<ref id="R21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lima</surname>
<given-names>C</given-names>
</name>
</person-group>
<year>2020</year>
<article-title>Information about the new coronavirus disease (COVID-19)</article-title>
<source>Radiologia brasileira</source>
<volume>53</volume>
<issue>2</issue>
<fpage>V</fpage>
<lpage>VI</lpage>
<pub-id pub-id-type="doi">10.1590/0100-3984.2020.53.2e1</pub-id>
</element-citation>
</ref>
<ref id="R22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Love</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>
<source>Genome biology</source>
<year>2014</year>
<volume>15</volume>
<issue>12</issue>
<fpage>550</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
</element-citation>
</ref>
<ref id="R23">
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Mantlo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bukreyeva</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Maruyama</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Paessler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Antiviral activities of type I interferons to SARS-CoV-2 infection</article-title>
<source>Antiviral research</source>
<year>2020</year>
<fpage>104811</fpage>
<pub-id pub-id-type="doi">10.1016/j.antiviral.2020.104811</pub-id>
</element-citation>
</ref>
<ref id="R24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathewson</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kemp</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Berkhout</surname>
<given-names>B</given-names>
</name>
<name>
<surname>van der Hoek</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>IM</given-names>
</name>
</person-group>
<article-title>Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin-converting enzyme-2</article-title>
<source>Journal of General Virology</source>
<year>2008</year>
<volume>89</volume>
<issue>11</issue>
<fpage>2741</fpage>
<lpage>2745</lpage>
<pub-id pub-id-type="doi">10.1099/vir.0.2008/003962-0</pub-id>
</element-citation>
</ref>
<ref id="R25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelemans</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kikkert</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections</article-title>
<source>Viruses</source>
<year>2019</year>
<volume>11</volume>
<issue>10</issue>
<pub-id pub-id-type="doi">10.3390/v11100961</pub-id>
</element-citation>
</ref>
<ref id="R26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newton</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Cardani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Braciale</surname>
<given-names>TJ</given-names>
</name>
</person-group>
<article-title>The host immune response in respiratory virus infection: balancing virus clearance and immunopathology</article-title>
<source>Seminars in Immunopathology</source>
<year>2016</year>
<volume>38</volume>
<issue>4</issue>
<fpage>471</fpage>
<lpage>482</lpage>
<pub-id pub-id-type="doi">10.1007/s00281-016-0558-0</pub-id>
</element-citation>
</ref>
<ref id="R27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phares</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>DiSano</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Stohlman</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Segal</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>CC</given-names>
</name>
</person-group>
<article-title>CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis</article-title>
<source>Brain, Behavior, and Immunity</source>
<year>2016</year>
<volume>54</volume>
<fpage>128</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2016.01.016</pub-id>
</element-citation>
</ref>
<ref id="R28">
<element-citation publication-type="web">
<collab>Pharmaceutical Technology</collab>
<year>2020</year>
<month>August</month>
<day>26</day>
<source>Covid-19 International update: Global Covid-19 cases near 24 million – deaths near 820,000 – more re-infections confirmed</source>
<comment>Retrieved from <ext-link ext-link-type="uri" xlink:href="https://www.pharmaceutical-technology.com/special-focus/covid-19/international-update-global-covid-19-cases-near-24-million-deaths-near-820000-more-re-infections-confirmed/">https://www.pharmaceutical-technology.com/special-focus/covid-19/international-update-global-covid-19-cases-near-24-million-deaths-near-820000-more-re-infections-confirmed/</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Randhawa</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Greninger</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Andriesen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Corey</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jerome</surname>
<given-names>KR</given-names>
</name>
</person-group>
<article-title>Changes in SARS-CoV-2 Positivity Rate in Outpatients in Seattle and Washington State, March 1–April 16, 2020</article-title>
<source>Jama</source>
<year>2020</year>
<volume>323</volume>
<issue>22</issue>
<fpage>2334</fpage>
<lpage>2336</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2020.8097</pub-id>
</element-citation>
</ref>
<ref id="R30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raudvere</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Kolberg</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kuzmin</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Arak</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Adler</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vilo</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)</article-title>
<source>Nucleic Acids Research</source>
<year>2019</year>
<volume>47</volume>
<issue>W1</issue>
<fpage>W191</fpage>
<lpage>W198</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkz369</pub-id>
</element-citation>
</ref>
<ref id="R31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China</article-title>
<source>Intensive Care Medicine</source>
<year>2020</year>
<volume>46</volume>
<issue>6</issue>
<fpage>1294</fpage>
<lpage>1297</lpage>
<pub-id pub-id-type="doi">10.1007/s00134-020-06028-z</pub-id>
</element-citation>
</ref>
<ref id="R32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scieglinska</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Krawczyk</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Sojka</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Gogler-Pigłowska</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Heat shock proteins in the physiology and pathophysiology of epidermal keratinocytes</article-title>
<source>Cell Stress and Chaperones</source>
<year>2019</year>
<volume>24</volume>
<issue>6</issue>
<fpage>1027</fpage>
<lpage>1044</lpage>
<pub-id pub-id-type="doi">10.1007/s12192-019-01044-5</pub-id>
</element-citation>
</ref>
<ref id="R33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shereen</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kazmi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bashir</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Siddique</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses</article-title>
<source>Journal of Advanced Research</source>
<year>2020</year>
<volume>24</volume>
<fpage>91</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1016/j.jare.2020.03.005</pub-id>
</element-citation>
</ref>
<ref id="R34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stahel</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Barnum</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option</article-title>
<source>Frontiers in Immunology</source>
<year>2020</year>
<volume>11</volume>
<fpage>1661</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2020.01661</pub-id>
</element-citation>
</ref>
<ref id="R35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sungnak</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bécavin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Queen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Litvinukova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Worlock</surname>
<given-names>KB</given-names>
</name>
</person-group>
<article-title>SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes</article-title>
<source>Nature medicine</source>
<year>2020</year>
<volume>26</volume>
<issue>5</issue>
<fpage>681</fpage>
<lpage>687</lpage>
<pub-id pub-id-type="doi">10.1038/s41591-020-0868-6</pub-id>
</element-citation>
</ref>
<ref id="R36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voineagu</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mill</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cantor</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Blencowe</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology</article-title>
<source>Nature</source>
<year>2011</year>
<volume>474</volume>
<issue>7351</issue>
<fpage>380</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1038/nature10110</pub-id>
</element-citation>
</ref>
<ref id="R37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions</article-title>
<source>Proceedings of the National Academy of Sciences</source>
<year>2020</year>
<volume>117</volume>
<issue>25</issue>
<fpage>13967</fpage>
<lpage>13974</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.2008209117</pub-id>
</element-citation>
</ref>
<ref id="R38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>
<article-title>Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients</article-title>
<source>Emerging Microbes &amp; Infections</source>
<year>2020</year>
<volume>9</volume>
<issue>1</issue>
<fpage>761</fpage>
<lpage>770</lpage>
<pub-id pub-id-type="doi">10.1080/22221751.2020.1747363</pub-id>
</element-citation>
</ref>
<ref id="R39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019</article-title>
<source>The Journal of Infectious Diseases</source>
<year>2020</year>
<volume>222</volume>
<issue>1</issue>
<fpage>34</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1093/infdis/jiaa224</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<boxed-text id="BX1" position="float" orientation="portrait">
<caption>
<title>Highlights</title>
</caption>
<list list-type="bullet" id="L1">
<list-item>
<p id="P25">Transcriptomic profiling from publicly available RNA-seq count data revealed a site-specific immune response in COVID-19.</p>
</list-item>
<list-item>
<p id="P26">Host response was found cellular-mediated in nasopharyngeal samples and humoral-mediated in PBMCs samples.</p>
</list-item>
<list-item>
<p id="P27">
<italic>CXCL13</italic>, <italic>GABRE</italic> and <italic>IFITM3</italic> commonly upregulated and <italic>HSPA1B</italic> downregulated in both sample groups highlights the potential of these molecules as markers of response to SARSCoV-2 infection.</p>
</list-item>
</list>
</boxed-text>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>Schematic representation of the workflow in the present study.</title>
<p>(1) Gene expression data (RNA-Seq counts) of GSE152418 and GSE152075 datasets were downloaded from the NCBI Gene Expression Omnibus (GEO) database. (2) Differentially expressed gene (DEG) analysis was performed on the control and disease sample groups in each nasopharyngeal and PBMC group using the DESeq2 package in R. Genes that fulfilled the criteria of an adjusted <italic>p</italic>-value &lt; 0.05 and a threshold of log2 fold change &gt; 1 were considered significant. (3) Ensembl IDs of DEGs were converted to HUGO Gene Nomenclature Committee (HGNC) symbols using the g: Convert tool in g: Profiler. (4) An ensemble of hierarchical and k-means clustering was then applied to common DEGs in both the nasopharyngeal and PBMC sample groups and DEGs were also searched for their involvement in innate immunity using the InnateDB database. (5) Functional profiling of DEGs in the two sample groups were carried out using the g:GOSt tool in g: Profiler with adjusted p-value &lt; 0.05 set as cut off for significant terms. (6) Associated gene ontology (GO), molecular function (MF), biological process (BP), KEGG pathway, Reactome pathway, and WikiPathway was identified for each dataset.</p>
</caption>
<graphic xlink:href="EMS94921-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<title>Transcriptomic mapping of nasopharyngeal and PBMC samples in healthy and COVID-19 individuals.</title>
<p>Principal component analysis (PCA) from nasopharyngeal samples (A) and PBMC samples (B). Cyan: negative to infection by SARS-CoV-2 (healthy); Pink: positive to infection by SARS-CoV-2 (case). Volcano plots showing the expression of the genes upregulated (red), downregulated (blue) or not differentially expressed (black) in nasopharyngeal samples (C) and PBMCs samples (D).</p>
</caption>
<graphic xlink:href="EMS94921-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<title>Differential expression of genes in nasopharyngeal and PBMC samples from COVID-19 patients.</title>
<p>Heatmaps of gene expression intensity in data series show relative intensity of expression, varying from downregulated (green) to upregulated (red). Shown are the top significant DEGs in healthy donors (negative, blue bar) and COVID-19 patients (positive, yellow bar) in the nasopharyngeal sample group (A) and PBMCs sample group (B). Hierarchical clustering from the common expression of the thirteen genes in nasopharyngeal samples (pink) and PBMCs samples (blue) in patients with COVID-19 (C).</p>
</caption>
<graphic xlink:href="EMS94921-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<title>Functional profile of top 15 terms in COVID-19 subjects in nasopharyngeal (A) and PBMC (B) sample groups.</title>
<p>Annotations state primarily immune-related functions (red) and metabolic-related functions (blue) played by differentially expressed genes (DEGs) shown in Log10 adjusted p value.</p>
</caption>
<graphic xlink:href="EMS94921-f004"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<title>Cellular and molecular alterations in SARS-CoV-2 infection in nasopharyngeal and PBMC samples.</title>
<p>Proposed mechanism of the immune response against SARS-CoV-2 infection from functional profiling suggested an innate immunity profile in nasopharyngeal and PBMC samples. Commonly expressed genes appear in upregulation of <italic>CXCL13, GABRE</italic> and <italic>IFITM3</italic> and downregulation of <italic>HSPA1B</italic> for both nasopharyngeal and PBMC samples, downregulation of <italic>CLU</italic>, <italic>IGHA2</italic>, <italic>IGHG1</italic>, <italic>IGHG3</italic>, <italic>ITGB5, MT1E, SELENBP1, TXNDC5</italic> and <italic>UCHL1</italic> in nasopharyngeal sample and upregulation in PBMC sample. The nasopharyngeal sample revealed an inflammatory response cellular mediated against SARS-CoV-2 infection. Viral protein interaction between cytokine and cytokine receptor occurs (1) in antigen-presenting cells, producing cytokines/chemokines (2) and creating a signalling gradient to favour leukocyte migration (3) to the site of infection. PBMCs sample displayed a humoral response, played by circulating immunoglobulin production mediated by B cells (4) that promote antigen binding, activating the classical pathway of complement system cascade (5). Creation of C4 and C2 activators occurs (6) and cleavages into C2a and C4b (7) to initiate C3 and so on to complete the activation of the complement cascade.</p>
</caption>
<graphic xlink:href="EMS94921-f005"/>
</fig>
</floats-group>
</article>
